Quarterly report pursuant to Section 13 or 15(d)

SIGNIFICANT ACCOUNTING POLICIES - Net Loss Per Common Share (Details)

v3.23.1
SIGNIFICANT ACCOUNTING POLICIES - Net Loss Per Common Share (Details) - $ / shares
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
SIGNIFICANT ACCOUNTING POLICIES    
Shares excluded from the calculation of weighted average dilutive common shares 5,600,812 6,380,001
Number of warrants exercisable (in shares) 368,711  
Warrants term (in years) 5 years  
Warrants to purchase shares of common stock 368,711  
Exercise price of warrants (in dollars per share) $ 5.50  
Warrants    
SIGNIFICANT ACCOUNTING POLICIES    
Shares excluded from the calculation of weighted average dilutive common shares 4,980,963 5,122,074
Restricted stock units    
SIGNIFICANT ACCOUNTING POLICIES    
Shares excluded from the calculation of weighted average dilutive common shares 531,095 855,989
Restricted stock awards    
SIGNIFICANT ACCOUNTING POLICIES    
Shares excluded from the calculation of weighted average dilutive common shares 52,087 307,491
Stock options    
SIGNIFICANT ACCOUNTING POLICIES    
Shares excluded from the calculation of weighted average dilutive common shares 36,667 94,447